Counseling the Patient with HPV Disease

Obstetrics and Gynecology Clinics of North America

Volumn 40, Issue 2, 2013, Pages 391-402

  Diaz, Maria Lina ^a  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

Abnormal cytology; Colposcopy; Genital warts; High risk HPV DNA test; Human papillomavirus; Loop electrosurgical excision procedure

Indexed keywords

DICHLOROACETIC ACID; GREEN TEA EXTRACT; IMIQUIMOD; PODOPHYLLIN; TRICHLOROACETIC ACID; VIRUS DNA; WART VIRUS VACCINE;

AGE; ANUS CANCER; ANXIETY; ASYMPTOMATIC INFECTION; CANCER GROWTH; COLPOSCOPY; CONDYLOMA ACUMINATUM; CRYOSURGERY; DEPRESSION; DISTRESS SYNDROME; DNA DETERMINATION; ELECTROSURGERY; EXCISION; GYNECOLOGIC CANCER; HIGH RISK PATIENT; HUMAN; IMMUNIZATION; INFECTION RISK; LIFESTYLE MODIFICATION; LOOP ELECTROSURGICAL EXCISION PROCEDURE; NONHUMAN; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PATIENT COUNSELING; PATIENT EDUCATION; PERSISTENT VIRUS INFECTION; PRECANCER; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SOCIAL PSYCHOLOGY; SURGICAL TECHNIQUE; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; UTERUS BIOPSY; VACCINATION; VIRUS STRAIN; VIRUS TRANSMISSION; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; CONDYLOMATA ACUMINATA; COUNSELING; FEMALE; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; MASS SCREENING; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT EDUCATION AS TOPIC; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84878662591     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2013.02.003     Document Type: Review

References (57)

1. Winer R.L., Lee S.K., Hughes J.P., et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003, 157:218-226.
2. Brown D.R., Schroeder J.M., Bryan J.Y., et al. Detection of multiple human papillomavirus types in condyloma acuminata lesions from otherwise healthy and immunocompromised patients. J Clin Microbiol 1999, 37:3316-3322.
3. Quick C.A., Watts S.L., Krzyzek R.A., et al. Relationship between condyloma and laryngeal papillomata. Clinical and molecular evidence. Ann Otol Rhinol Laryngol 1980, 89:467-471.
4. Kashima H.K., Shah F., Lyles A., et al. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope 1992, 102:9-13.
5. Koutsky L.A., Galloway D.A., Holmes K.K. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988, 10:122-163.
6. Wharton J.T., Totolero-Luna G., Linares A.C., et al. Vaginal intraepithelial neoplasia and vaginal cancer. Obstet Gynecol Clin North Am 1996, 23:325-345.
7. Jones R.W., Rowan D.M. Vulvar intraepithelial neoplasia III: a clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma. Obstet Gynecol 1994, 84:741-745.
8. Gillison M.L., Koch W.M., Copone R.B., et al. Evidence for causal association between Human Papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000, 92:709-720.
9. Sung H.Y., Keaerney K.A., Miller M., et al. Papanicolaou smear history and the diagnosis of invasive cervical cancer among members of a large prepaid health plan. Cancer 2000, 88:2283-2289.
10. Herrington C.S. Human papilloma virus and cervical neoplasia II. Interaction of HPV with other factors. J Clin Pathol 1995, 48:1.
11. Smith J.S., Herrero R., Boseetti C., et al. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 2002, 94:1604-1613.
12. Plummer M., Herrero R., Franceschi S., et al. Smoking and cervical cancer: pooled analysis of the IARC multicentric case-control study. Cancer Causes Control 2003, 14:805-814.
13. Moreno V., Bosch F.X., Munoz N., et al. International agency for research on cancer multicentric cervical cancer study group. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 2002, 359:1085-1092.
14. Chilvers C., Mant D., Pike M.C. Cervical adenocarcinoma and oral contraceptives. BMJ 1987, 295:1446-1447.
15. Levi J.E., Kleter B., Quint W.G., et al. High prevalence of human papillomavirus (HPV) infections and high risk frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002, 40:3341-3345.
16. Penn I. Cancers of the anogenital region in renal transplant patients. Cancer 1986, 58:611-616.
17. Winer R.L., Hughes J.P., Fen Q., et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006, 354:2645-2654.
18. Miksis S. A review of the evidence comparing the human papillomavirus vaccine versus condoms in the prevention of human papillomavirus infections. J Obstet Gynecol Neonatal Nurs 2008, 37:329-337.
19. Gardasil [package insert]. Whitehouse Station, NJ: Merck and CO, Inc; 2010. Available at: . Accessed December 8, 2012. http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM111263.pdf.
20. Cervarix [package insert]. Rixensart, Belgium: GlaxoSmithKline Biologists; 2011. Available at: . Accessed December 8, 2012. http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM186981.pdf.
21. Centers for Disease Control and Prevention (CDC) FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunizations Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010, 59:626-629. [Erratum appears in MMWR Morb Mortal Wkly Rep 2010;59:1184].
22. Markowits L.E., Dunne E.F., Saraiya M., et al. Quadrivalent human papillomavirus vaccines: recommendations of the Advisory Committee of Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56(RR-2):1-24.
23. Human papillomavirus vaccination. Committee Opinion No.467. Obstet Gynecol 2010, 116:800-803. American College of Obstetricians and Gynecologists.
24. Velicer C. Post-licensure safety study of quadrivalent human papillomavirus vaccines among 189,629 females. Paper presented at: advisory committee on immunization practices meeting. Atlanta, October 25, 2011. Available at: . Accessed November 27, 2012. http://www.cdc.gov/VACCINes/recs/acip/downloads/mtg-slides-oct11/03-HPV-CVelicer.pdf.
25. Shepherd J.P., Fampton G.K., Harris P. Interventions for encouraging sexual behaviours intended to prevent cervical cancer. Cochrane Database Syst Rev 2011, (12). CD001035.
26. Department of Health and Human Services and Centers for Disease Control and Prevention. STD surveillance. 2004.
27. Garland S.M., Quinn M.A. How to manage and communicate with patients about HPV?. Int J Gynecol Obstet 2006, 94(Suppl 1):S106-S112.
28. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997, 102:3-8.
29. Sturgiss E.A., Jin F., Martin S.J., et al. Prevalence of other sexually transmissible infections in patients with newly diagnosed anogenital warts in a sexual health clinic. Sex Health 2010, 7:55-59.
30. Wiley D.J., Douglas J., Beutner K., et al. External genital warts: diagnosis, treatment and prevention. Clin Infect Dis 2002, 35:S210-S224.
31. Helberg D., Svarrer T., Nilsson E., et al. Self treatment of female genital warts with 0.5% podophyllotoxin cream (Condyline) vs weekly applications of 20% podophyllin solution. Int J STD AIDS 1995, 6:257-261.
32. Sauder D.N., Skinner R.B., Fox T.L., et al. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations. Sex Transm Dis 2003, 30:124-128.
33. Tatti S., Swinehart J.M., Thielert C., et al. Sinecatechins, a defined green tree extract, in the treatment of external genital warts: a randomized controlled trial. Obstet Gynecol 2008, 111:1371-1379.
34. Graziottin A., Serafini A. HPV infection in women: psychosexual impact of genital warts and intraepithelial lesions. J Sex Med 2009, 3:633-645.
35. Mortansen G.L., Larsen H.K. The quality of life of patients with genital warts: a qualitative study. BMC Public Health 2010, 10:113.
36. Steben M., Labelle D. Genital warts: Canadians' perception, health-related behaviors and treatment preferences. J Low Genit Tract Dis 2012, 4:409-415.
37. Henderson Z., Irwin K.L., Montana D.E., et al. Anogenital warts knowledge and counseling practices of US clinicians:results from a national survey. Sex Transm Dis 2007, 34:644-652.
38. McCaffery K., Waller J., Forrest S., et al. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact. BJOG 2004, 111:1437-1443.
39. Irwin K., Monatano D., Kasprzyk D., et al. Cervical cancer screening, abnormal cytology management, and counseling practices in the United States. Obstet Gynecol 2006, 108:397-409.
40. Monsonego J., Cortes J., da Silva D.P., et al. Psychological impact, support and information needs for women with an abnormal Pap smear: comparative results of a questionnaire in three European countries. BMC Womens Health 2011, 11:18.
41. Bertram C.C., Magnussen L. Information needs and the experiences of women with abnormal Papanicolaou smears. J Am Acad Nurse Pract 2008, 20:455-462.
42. Katki H.A., Kinney W.K., Fetterman B., et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population based study in routine practice. Lancet Oncol 2011, 12:663-672. [Erratum appears in Lancet Oncol 2011;12:722].
43. Saslow D., Solomon D., Lawson H.W., et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012, 62:147-172.
44. Byrom J., Dunn P.D., Hughes G.M., et al. Colposcopy information leaflets: what women want to know and when they want to receive this information. J Med Screen 2003, 10:143-147.
45. Ferris D.G., Gilman P.A., Leyva Lopez A.G., et al. Psychological effects women experience before and after a colposcopic examination and primary care appointment. J Low Genit Tract Dis 2003, 7:89-94.
46. Howells R.E., Dunn P.D., Isasi T., et al. Is the provision of information leaflets before colposcopy beneficial? A prospective randomized study. Br J Obstet Gynaecol 1999, 106:528-534.
47. de Bie R.P., Massuger L.F., Lenselink C.H., et al. The role of individually targeted information to reduce anxiety before colposcopy: a randomized control trial. BJOG 2011, 118:945-950.
48. Byrom J., Clarke T., Neale J., et al. Can pre-colposcopy sessions reduce anxiety at the time of colposcopy? A prospective randomized study. J Obstet Gynaecol 2002, 22:415-420.
49. Galaal K., Bryant A., Deane K.H., et al. Interventions for reducing anxiety in women undergoing colposcopy. Cochrane Database Syst Rev 2011, (7). CD006013.
50. Wright T.C., Massad L.S., Dunton C.J., et al. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis 2007, 11:223-239.
51. Bastani R., Yabroff K.R., Myers R.E., et al. Interventions to improve follow-up of abnormal findings in cancer screening. Cancer 2004, 101:1188-1200.
52. Le T., Hopkins L., Menard C., et al. Psychologic morbidities prior to loop electrosurgical excision procedure in the treatment of cervical intraepithelial neoplasia. Int J Gynecol Cancer 2006, 16:1089-1093.
53. Werner C., Lo J.Y., Heffernan T., et al. Loop electrosurgical excision procedure and risk of preterm birth. Obstet Gynecol 2010, 115:605-608.
54. Armarnik S., Sheiner E., Piura B., et al. Obstetric outcome following conization. Arch Gynecol Obstet 2011, 283:765-769.
55. Noehr B., Jensen A., Frederiksen K., et al. Depth of cervical cone removed by loop electrosurgical excision procedure and subsequent risk of spontaneous preterm delivery. Obstet Gynecol 2009, 114:1232-1238.
56. Hemmingsson E. Outcome of third-trimester pregnancies after cryotherapy of the uterine cervix. Br J Obstet Gynaecol 1982, 82:675-677.
57. Harper D.M., Mayeaux E.J., Daaleman T.P., et al. Healing experiences after cervical cryosurgery. J Fam Pract 2000, 49:701-706.